$ET
Energy Transfer LP

2023 Q2 Form 10-Q Financial Statement

#000127618723000035 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $18.32B $19.00B $20.49B
YoY Change -29.39% -7.3% 20.57%
Cost Of Revenue $14.09B $14.61B $16.14B
YoY Change -34.5% -9.47% 47.41%
Gross Profit $4.228B $4.385B $4.353B
YoY Change -4.56% 0.74% -28.01%
Gross Profit Margin 23.08% 23.09% 21.24%
Selling, General & Admin $228.0M $238.0M $230.0M
YoY Change 8.06% 3.48% 14.43%
% of Gross Profit 5.39% 5.43% 5.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.061B $1.059B $1.028B
YoY Change 1.43% 3.02% 7.76%
% of Gross Profit 25.09% 24.15% 23.62%
Operating Expenses $2.383B $238.0M $230.0M
YoY Change 1029.38% 3.48% 14.43%
Operating Profit $1.845B $2.062B $1.846B
YoY Change -12.68% 11.7% -54.63%
Interest Expense -$511.0M $619.0M $559.0M
YoY Change -188.41% 10.73% -5.09%
% of Operating Profit -27.7% 30.02% 30.28%
Other Income/Expense, Net $17.00M $5.000M $21.00M
YoY Change -194.44% -76.19% -450.0%
Pretax Income $1.341B $1.518B $1.478B
YoY Change -21.49% 2.71% -60.23%
Income Tax $108.0M $71.00M -$9.000M
% Of Pretax Income 8.05% 4.68% -0.61%
Net Earnings $797.0M $1.113B $1.269B
YoY Change -39.89% -12.29% -61.41%
Net Earnings / Revenue 4.35% 5.86% 6.19%
Basic Earnings Per Share
Diluted Earnings Per Share $0.25 $0.32 $409.3K
COMMON SHARES
Basic Shares Outstanding 3.097B shares 3.095B shares 3.083B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $330.0M $330.0M $1.111B
YoY Change -6.52% -70.3% 212.96%
Cash & Equivalents $330.0M $330.0M $1.111B
Short-Term Investments
Other Short-Term Assets $532.0M $546.0M $783.0M
YoY Change -26.72% -30.27% 237.5%
Inventory $2.271B $2.047B $1.981B
Prepaid Expenses
Receivables $7.383B $8.269B $9.965B
Other Receivables $82.00M $64.00M $68.00M
Total Short-Term Assets $10.60B $11.37B $15.70B
YoY Change -31.33% -27.58% 100.75%
LONG-TERM ASSETS
Property, Plant & Equipment $81.98B $80.00B $80.04B
YoY Change 2.64% -0.04% 6.99%
Goodwill $2.564B $2.566B $2.533B
YoY Change 0.43% 1.3% 5.94%
Intangibles $5.301B $5.322B $5.608B
YoY Change -5.46% -5.1% -0.87%
Long-Term Investments $3.007B $2.861B $2.921B
YoY Change 2.84% -2.05% -2.92%
Other Assets $1.687B $1.585B $1.566B
YoY Change 8.07% 1.21% -6.79%
Total Long-Term Assets $94.53B $93.15B $93.49B
YoY Change 1.28% -0.37% 5.76%
TOTAL ASSETS
Total Short-Term Assets $10.60B $11.37B $15.70B
Total Long-Term Assets $94.53B $93.15B $93.49B
Total Assets $105.1B $104.5B $109.2B
YoY Change -3.34% -4.28% 13.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.179B $6.934B $8.653B
YoY Change -30.55% -19.87% 82.86%
Accrued Expenses $3.368B $3.213B $3.247B
YoY Change -2.57% -1.05% 12.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.459B $2.000M $652.0M
YoY Change 172850.0% -99.69% 2734.78%
Total Short-Term Liabilities $13.01B $10.16B $13.72B
YoY Change -3.43% -25.93% 76.36%
LONG-TERM LIABILITIES
Long-Term Debt $44.67B $47.23B $48.83B
YoY Change -7.13% -3.27% 2.33%
Other Long-Term Liabilities $2.151B $1.374B $1.337B
YoY Change 56.32% 2.77% 11.6%
Total Long-Term Liabilities $46.82B $48.60B $50.16B
YoY Change -5.37% -3.11% 2.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.01B $10.16B $13.72B
Total Long-Term Liabilities $46.82B $48.60B $50.16B
Total Liabilities $71.58B $58.77B $63.88B
YoY Change 13.7% -8.01% 12.69%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $33.55B $33.15B $32.00B
YoY Change
Total Liabilities & Shareholders Equity $105.1B $104.5B $109.2B
YoY Change -3.34% -4.28% 13.48%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $797.0M $1.113B $1.269B
YoY Change -39.89% -12.29% -61.41%
Depreciation, Depletion And Amortization $1.061B $1.059B $1.028B
YoY Change 1.43% 3.02% 7.76%
Cash From Operating Activities $2.536B $3.350B $2.370B
YoY Change 7.73% 41.35% -54.03%
INVESTING ACTIVITIES
Capital Expenditures $876.0M $853.0M -$752.0M
YoY Change -224.08% -213.43% 7.74%
Acquisitions $0.00 $589.0M
YoY Change -100.0%
Other Investing Activities -$1.012B $50.00M -$519.0M
YoY Change -4500.0% -109.63%
Cash From Investing Activities -$1.888B -$803.0M -$1.271B
YoY Change 176.43% -36.82% 100.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $8.605B $5.428B
YoY Change 58.53% -35.98%
Cash From Financing Activities -648.0M -$2.474B -$324.0M
YoY Change -73.32% 663.58% -92.85%
NET CHANGE
Cash From Operating Activities 2.536B $3.350B $2.370B
Cash From Investing Activities -1.888B -$803.0M -$1.271B
Cash From Financing Activities -648.0M -$2.474B -$324.0M
Net Change In Cash 0.000 $73.00M $775.0M
YoY Change -100.0% -90.58% -6558.33%
FREE CASH FLOW
Cash From Operating Activities $2.536B $3.350B $2.370B
Capital Expenditures $876.0M $853.0M -$752.0M
Free Cash Flow $1.660B $2.497B $3.122B
YoY Change -45.75% -20.02% -46.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75225
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001276187
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0Y9M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y9M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y9M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y9M
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-32740
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ENERGY TRANSFER LP
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-0108820
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8111 Westchester Drive
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 600
CY2023Q1 dei City Area Code
CityAreaCode
214
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
981-0700
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3096774774 shares
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
330000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
257000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8269000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8466000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2047000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2461000000 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
64000000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
68000000 usd
CY2023Q1 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
6000000 usd
CY2022Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
10000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
546000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
726000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
11370000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
12081000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
106643000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
105996000000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26639000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25685000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80004000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80311000000 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
2861000000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
2893000000 usd
CY2023Q1 et Lease Rightof Use Asset Net
LeaseRightofUseAssetNet
813000000 usd
CY2022Q4 et Lease Rightof Use Asset Net
LeaseRightofUseAssetNet
819000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1585000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1558000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5322000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5415000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2566000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2566000000 usd
CY2023Q1 us-gaap Assets
Assets
104521000000 usd
CY2022Q4 us-gaap Assets
Assets
105643000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6934000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6952000000 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4000000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
23000000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45000000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3168000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3329000000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10162000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10368000000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
47229000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
48260000000 usd
CY2023Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
43000000 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
23000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
791000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
798000000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
3759000000 usd
CY2022Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
3701000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1374000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1341000000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Other Carrying Amount
RedeemableNoncontrollingInterestEquityOtherCarryingAmount
494000000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Other Carrying Amount
RedeemableNoncontrollingInterestEquityOtherCarryingAmount
493000000 usd
CY2023Q1 us-gaap Preferred Units Preferred Partners Capital Accounts
PreferredUnitsPreferredPartnersCapitalAccounts
6080000000 usd
CY2022Q4 us-gaap Preferred Units Preferred Partners Capital Accounts
PreferredUnitsPreferredPartnersCapitalAccounts
6051000000 usd
CY2023Q1 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
27057000000 usd
CY2022Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
26960000000 usd
CY2023Q1 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
-2000000 usd
CY2022Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
-2000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
13000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
16000000 usd
CY2023Q1 us-gaap Partners Capital
PartnersCapital
33148000000 usd
CY2022Q4 us-gaap Partners Capital
PartnersCapital
33025000000 usd
CY2023Q1 us-gaap Partners Capital Attributable To Noncontrolling Interest
PartnersCapitalAttributableToNoncontrollingInterest
7521000000 usd
CY2022Q4 us-gaap Partners Capital Attributable To Noncontrolling Interest
PartnersCapitalAttributableToNoncontrollingInterest
7634000000 usd
CY2023Q1 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
40669000000 usd
CY2022Q4 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
40659000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104521000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
105643000000 usd
CY2023Q1 us-gaap Revenues
Revenues
18995000000 usd
CY2022Q1 us-gaap Revenues
Revenues
20491000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14610000000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16138000000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1025000000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
949000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1059000000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1028000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
238000000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
230000000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
300000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
16933000000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
18645000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2062000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1846000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
619000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
559000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
88000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
56000000 usd
CY2023Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-20000000 usd
CY2022Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
114000000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7000000 usd
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
21000000 usd
CY2023Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1518000000 usd
CY2022Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1478000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
71000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1447000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1487000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
321000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
205000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
13000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
13000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1113000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1269000000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
1000000 usd
CY2022Q1 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
1000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
109000000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
106000000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
1003000000 usd
CY2022Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
1162000000 usd
CY2023Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
0.32
CY2022Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
0.38
CY2023Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
0.32
CY2022Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
0.37
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1447000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1487000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-5000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
5000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-7000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
11000000 usd
CY2023Q1 et Changeinothercomprehensiveincomefromequityinvestments
Changeinothercomprehensiveincomefromequityinvestments
0 usd
CY2022Q1 et Changeinothercomprehensiveincomefromequityinvestments
Changeinothercomprehensiveincomefromequityinvestments
12000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1444000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1512000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
321000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
210000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
13000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
13000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1110000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1289000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40659000000 usd
CY2023Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
1001000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
441000000 usd
CY2023Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
3000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000000 usd
CY2023Q1 us-gaap Partners Capital Other
PartnersCapitalOther
18000000 usd
CY2023Q1 et Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Portion Attributableto Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingPortionAttributabletoRedeemableNoncontrollingInterest
1434000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40669000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39345000000 usd
CY2022Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
608000000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
307000000 usd
CY2022Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
373000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000000 usd
CY2022Q1 us-gaap Partners Capital Other
PartnersCapitalOther
27000000 usd
CY2022Q1 et Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Portion Attributableto Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingPortionAttributabletoRedeemableNoncontrollingInterest
1474000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40329000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1447000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1487000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1059000000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1028000000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-53000000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-32000000 usd
CY2023Q1 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-29000000 usd
CY2022Q1 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-120000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
37000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
36000000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
300000000 usd
CY2023Q1 et Distributions On Unvested Unit Awards
DistributionsOnUnvestedUnitAwards
20000000 usd
CY2022Q1 et Distributions On Unvested Unit Awards
DistributionsOnUnvestedUnitAwards
15000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
88000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
56000000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
87000000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
44000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2000000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
46000000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-801000000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
320000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3350000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2370000000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
589000000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
853000000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
752000000 usd
CY2023Q1 us-gaap Proceeds From Contribution In Aid Of Construction
ProceedsFromContributionInAidOfConstruction
16000000 usd
CY2022Q1 us-gaap Proceeds From Contribution In Aid Of Construction
ProceedsFromContributionInAidOfConstruction
20000000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
30000000 usd
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
46000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
4000000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
4000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-803000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1271000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7582000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5658000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8605000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5428000000 usd
CY2023Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
3000000 usd
CY2022Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
373000000 usd
CY2023Q1 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
1001000000 usd
CY2022Q1 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
608000000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
441000000 usd
CY2022Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
307000000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
12000000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
12000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2474000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-324000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
73000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
775000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
257000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
336000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
330000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1111000000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements have been prepared in conformity with GAAP, which requires the use of estimates and assumptions made by management that affect the reported amounts of assets, liabilities, revenues, expenses and the accrual for and disclosure of contingent assets and liabilities that exist at the date of the consolidated financial statements. Although these estimates are based on management’s available knowledge of current and expected future events, actual results could be different from those estimates.</span></div>
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-11000000 usd
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
7000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-197000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2412000000 usd
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
3000000 usd
CY2022Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
17000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-429000000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-153000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-188000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
119000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-45000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-18000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1885000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13000000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
230000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
31000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
61000000 usd
CY2023Q1 us-gaap Increase Decrease In Risk Management Assets And Liabilities
IncreaseDecreaseInRiskManagementAssetsAndLiabilities
-5000000 usd
CY2022Q1 us-gaap Increase Decrease In Risk Management Assets And Liabilities
IncreaseDecreaseInRiskManagementAssetsAndLiabilities
153000000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-801000000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
320000000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
436000000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
475000000 usd
CY2023Q1 et Rightof Use Assets Obtainedin Exchangefor Liabilities
RightofUseAssetsObtainedinExchangeforLiabilities
1000000 usd
CY2022Q1 et Rightof Use Assets Obtainedin Exchangefor Liabilities
RightofUseAssetsObtainedinExchangeforLiabilities
56000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
23000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
12000000 usd
CY2023Q1 us-gaap Energy Related Inventory Natural Gas In Storage
EnergyRelatedInventoryNaturalGasInStorage
1419000000 usd
CY2022Q4 us-gaap Energy Related Inventory Natural Gas In Storage
EnergyRelatedInventoryNaturalGasInStorage
1802000000 usd
CY2023Q1 us-gaap Inventory Crude Oil Products And Merchandise
InventoryCrudeOilProductsAndMerchandise
184000000 usd
CY2022Q4 us-gaap Inventory Crude Oil Products And Merchandise
InventoryCrudeOilProductsAndMerchandise
246000000 usd
CY2023Q1 us-gaap Other Inventory Supplies
OtherInventorySupplies
444000000 usd
CY2022Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
413000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2047000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2461000000 usd
CY2023Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
0.32
CY2023Q1 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-29000000 usd
CY2022Q1 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-120000000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2023Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
44430000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
47230000000 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
45420000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
48260000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1447000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1487000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
321000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
205000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
13000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
13000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1113000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1269000000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
1000000 usd
CY2022Q1 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
1000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
109000000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
106000000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
1003000000 usd
CY2022Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
1162000000 usd
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
3095500000 shares
CY2022Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
3083500000 shares
CY2022Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
0.38
CY2023Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
1003000000 usd
CY2022Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
1162000000 usd
CY2023Q1 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2022Q1 us-gaap Dilutive Securities
DilutiveSecurities
-1000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1003000000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1161000000 usd
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
3095500000 shares
CY2022Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
3083500000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
19900000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
17000000.0 shares
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
3115400000 shares
CY2022Q1 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
3100500000 shares
CY2023Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
0.32
CY2022Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
0.37
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
23000000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
709000000 usd
CY2023Q1 us-gaap Supplementary Leverage Ratio
SupplementaryLeverageRatio
3.26
CY2022Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
3094400000 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
1800000 shares
CY2023Q1 us-gaap Partners Capital Account Units Unitbased Compensation
PartnersCapitalAccountUnitsUnitbasedCompensation
500000 shares
CY2023Q1 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
3096700000 shares
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
880000000 usd
CY2023Q1 et Common Units Remaining Availabletobe Issued Under Distribution Reinvestment Plan
CommonUnitsRemainingAvailabletobeIssuedUnderDistributionReinvestmentPlan
10000000 shares
CY2022Q4 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.3050
CY2022Q1 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.3075
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
10000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
9000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4000000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-6000000 usd
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-7000000 usd
CY2023Q1 et Aoci Attributable To Equity Method Investments
AociAttributableToEquityMethodInvestments
13000000 usd
CY2022Q4 et Aoci Attributable To Equity Method Investments
AociAttributableToEquityMethodInvestments
13000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
13000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
16000000 usd
CY2023Q1 et Contractual Rightof Way Expense
ContractualRightofWayExpense
13000000 usd
CY2022Q1 et Contractual Rightof Way Expense
ContractualRightofWayExpense
14000000 usd
CY2023Q1 us-gaap Loss Contingency Range Of Possible Loss Portion Not Accrued
LossContingencyRangeOfPossibleLossPortionNotAccrued
800000000 usd
CY2023Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
161000000 usd
CY2023Q1 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
49000000 usd
CY2022Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
54000000 usd
CY2023Q1 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
227000000 usd
CY2022Q4 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
228000000 usd
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
276000000 usd
CY2022Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
282000000 usd
CY2023Q1 us-gaap Payments For Environmental Liabilities
PaymentsForEnvironmentalLiabilities
8000000 usd
CY2022Q1 us-gaap Payments For Environmental Liabilities
PaymentsForEnvironmentalLiabilities
4000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
615000000 usd
CY2023Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
278000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-301000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
592000000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
459000000 usd
CY2022Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
266000000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-209000000 usd
CY2022Q1 us-gaap Deferred Revenue Period Increase Decrease
DeferredRevenuePeriodIncreaseDecrease
-10000000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
506000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
39060000000.00 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1
2023
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1
2024
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1
2025
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5495000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6360000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5429000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
21775000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
39059000000 usd
CY2023Q1 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.03785 rate
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Risk</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk refers to the risk that a counterparty may default on its contractual obligations resulting in a loss to the Partnership. Credit policies have been approved and implemented to govern the Partnership’s portfolio of counterparties with the objective of mitigating credit losses. These policies establish guidelines, controls and limits to manage credit risk within approved tolerances by mandating an appropriate evaluation of the financial condition of existing and potential counterparties, monitoring agency credit ratings, and by implementing credit practices that limit exposure according to the risk profiles of the counterparties. Furthermore, the Partnership may, at times, require collateral under certain circumstances to mitigate credit risk as necessary. The Partnership also uses industry standard commercial agreements which allow for the netting of exposures associated with transactions executed under a single commercial agreement. Additionally, we utilize master netting agreements to offset credit exposure across multiple commercial agreements with a single counterparty or affiliated group of counterparties.</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our natural gas transportation and midstream revenues are derived significantly from companies that engage in exploration and production activities. In addition to oil and gas producers, the Partnership’s counterparties consist of a diverse portfolio of customers across the energy industry, including petrochemical companies, commercial and industrial end-users, municipalities, gas and electric utilities, midstream companies and independent power generators. Our overall exposure may be affected positively or negatively by macroeconomic or regulatory changes that impact our counterparties to one extent or another. Currently, management does not anticipate a material adverse effect in our financial position or results of operations as a consequence of counterparty non-performance.</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Partnership has maintenance margin deposits with certain counterparties in the OTC market, primarily with independent system operators and with clearing brokers. Payments on margin deposits are required when the value of a derivative exceeds our pre-established credit limit with the counterparty. Margin deposits are returned to us on or about the settlement date for non-exchange traded derivatives, and we exchange margin calls on a daily basis for exchange traded transactions. Since the margin calls are made daily with the exchange brokers, the fair value of the financial derivative instruments are deemed current and netted in deposits paid to vendors within other current assets in the consolidated balance sheets. </span></div>For financial instruments, failure of a counterparty to perform on a contract could result in our inability to realize amounts that have been recorded on our consolidated balance sheets and recognized in net income or other comprehensive income.
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
105000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
361000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
688000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
352000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
549000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
361000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
688000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
352000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
549000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
100000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
244000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
91000000 usd
CY2023Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-20000000 usd
CY2022Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
114000000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
36000000 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
114000000 usd
CY2023Q1 us-gaap Revenues
Revenues
18995000000 usd
CY2022Q1 us-gaap Revenues
Revenues
20491000000 usd
CY2023Q1 et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
3433000000 usd
CY2022Q1 et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
3340000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1447000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1487000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1059000000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1028000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
619000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
559000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
71000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
300000000 usd
CY2023Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-20000000 usd
CY2022Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
114000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
37000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
36000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
130000000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
45000000 usd
CY2023Q1 us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
-29000000 usd
CY2022Q1 us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
-120000000 usd
CY2023Q1 et Adjusted Ebitda Related To Unconsolidated Affiliates
AdjustedEBITDARelatedToUnconsolidatedAffiliates
161000000 usd
CY2022Q1 et Adjusted Ebitda Related To Unconsolidated Affiliates
AdjustedEBITDARelatedToUnconsolidatedAffiliates
125000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
88000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
56000000 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
5000000 usd
CY2022Q1 us-gaap Other Expenses
OtherExpenses
59000000 usd
CY2023Q1 et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
3433000000 usd
CY2022Q1 et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
3340000000 usd

Files In Submission

Name View Source Status
et-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001276187-23-000035-index-headers.html Edgar Link pending
0001276187-23-000035-index.html Edgar Link pending
0001276187-23-000035.txt Edgar Link pending
0001276187-23-000035-xbrl.zip Edgar Link pending
et-20230331.htm Edgar Link pending
et-20230331.xsd Edgar Link pending
et-20230331_g1.jpg Edgar Link pending
et03-31x2023ex311.htm Edgar Link pending
et03-31x2023ex312.htm Edgar Link pending
et03-31x2023ex313.htm Edgar Link pending
et03-31x2023ex321.htm Edgar Link pending
et03-31x2023ex322.htm Edgar Link pending
et03-31x2023ex323.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
et-20230331_def.xml Edgar Link unprocessable
et-20230331_lab.xml Edgar Link unprocessable
et-20230331_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
et-20230331_pre.xml Edgar Link unprocessable